Role of fructose in obesity, a new perspective
HQ Team October 20, 2023: A new research paper suggests that fructose, a type of sugar, maybe a significant driver of obesity. While.
Drugs
Health
Medical
Drugs
Health
Medical
Innovative magnetic gel accelerates diabetic wound healing
HQ Team October 20, 2023: More than half a billion people worldwide are living with diabetes, and this number is expected to rise..
Drugs
Health
Pharma
Scientists connect gut microbiota to Alzheimer’s disease in lab experiments
HQ Team October 19, 2023: Experiments conducted on young adult rats have established a link between Alzheimer’s and gut microbiota, according to a.
Drugs
Health
Pharma
Belgium’s Hyloris gets nod for post-operative pain reduction drug
HQ Team October 18, 2023: Hyloris Pharmaceuticals SA, Liège, Belgium-based biopharma company, announced the US Food and Drug Administration has approved its post-operative.
Drugs
Health
Pharma
Novo Nordisk to buy hypertension drug from KBP for $1.3 billion
HQ Team October 16, 2023: Danish pharmaceutical company, Novo Nordisk, announced it was buying a hypertension drug, still in trials, from Singapore-based KBP.
Drugs
Health
Pharma
BioNTech expects revenue to be lower in 2023 as Covid-19 vaccine sales fall
HQ Team October 16, 2023: Germany’s BioNTech announced its partner Pfizer Inc.’s write-offs for inventory and other charges related to the Covid-19 Comirnaty.
Drugs
Health
Pharma
ImmunoACT gets nod for leukaemia, lymphoma cancer therapy in India
HQ Team October 16, 2023: India’s Immunoactive Cell Therapy Ltd., has got a marketing authorisation from the drug regulator for a therapy to.
Drugs
Health
Pharma
Opinion: Sheela’s death shook me, stray dogs with rabies scare me
By Dr K. Leelamoni October 16, 2023: Sheela, 19, a student studying medicine in India’s southern city of Thiruvananthapuram, was bitten by a.
Drugs
Health
Pharma
Eli Lilly late-stage trial drug for Crohn’s disease meets testing goals
HQ Team October 13, 2023: Eli Lilly and Company announced its experimental drug for treating severe Crohn’s disease met secondary targets in efficacy.
Drugs
Health
Pharma
FDA nod for Pfizer’s combination therapy for non-small cell cancer
HQ Team October 12, 2023: The Food and Drug Administration has approved Pfizer Inc.’s treatment for metastatic non-small cell lung cancer. The FDA.